Title : Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.

Pub. Date : 2006 Mar

PMID : 16282336






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation. Eicosapentaenoic Acid chemokine (C-C motif) ligand 2 Mus musculus
2 RESULTS: EPA decreased the levels of serum triglycerides, leptin, urinary albumin and MCP-1, and improved glucose intolerance, mesangial matrix accumulation and tubulointerstitial fibrosis in KKAy/Ta mice. Eicosapentaenoic Acid chemokine (C-C motif) ligand 2 Mus musculus
3 Immunohistochemical staining of MCP-1 and F4/80 in the glomeruli and tubulointerstitial regions was decreased in the EPA-treated group. Eicosapentaenoic Acid chemokine (C-C motif) ligand 2 Mus musculus
4 EPA and specific inhibitors of ERK1/2, JNK and PI3K decreased levels of MCP-1 in MMCs. Eicosapentaenoic Acid chemokine (C-C motif) ligand 2 Mus musculus